Most patients describe it as food noise finally turning down
Approximately 66% of researchers who try microdosing cite side effect reduction as their primary motivation
Tirzepatide carries warnings for thyroid C-cell tumors (based on rodent studies), acute pancreatitis, gallbladder disease, acute kidney injury, diabetic retinopathy complications in patients with diabetes, and hypoglycemia when used with insulin or sulfonylureas
The goal is not dependency on an external signal but restoration of internal regulation
This is why appetite suppression works you feel full longer
In a large clinical trial sponsored by Novo Nordisk, the manufacturer of Ozempic and Wegovy, participants were randomly assigned to either receive semaglutide or the matching placebo